| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1bbd594ea6c76a0084b1595735d04de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51a0c49e5390c69aa92b87c3a892344c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0029eb35ef236b73d8d2aa3d1e516189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20e53de16597d11a7d5266562e079371 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-00 |
| filingDate |
2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0574f3af8890ae3c795e5a491cd64194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3c6889e8cec93c994ba0886a824541e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a17dbcbace1c4f21f3033879b587fe9c |
| publicationDate |
2013-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013148994-A1 |
| titleOfInvention |
Glucose transporter inhibitors |
| abstract |
Thiazolidinedione compounds and pharmaceutically acceptable salts thereof are described. The compounds can be used in methods of treating cancer in a subject by administering to the subject a therapeutically effective amount of the compound. The compounds can also be used in methods of inhibiting glucose uptake in a cell by contacting the cell with the compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10316287-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10808222-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015112581-A1 |
| priorityDate |
2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |